kageyd
02-09-2010, 07:56 AM
I found myself wanting to know more about the anti-CCP test. Here are two quoted snippets that, for me, cut through the more fuzzy scientific wordings to get to what we really want to know. Perhaps this will be of interest to others. It seems clear to me after reading more that specific numbers of anti-CCP, except in a general “high low” sense, are not yet of direct usefulness in treatment. Italics and bold lettering is mine.
1. What is cyclic citrulline peptide (antibody)y, anti-CCP, quoted from MedicineNet.com: “Citrulline antibody: An antibody … directed against a circular peptide … containing an unusual ("non-standard") amino acid called citrulline that is not normally present in peptides or proteins. … The citrulline antibody provides the basis for a test of importance in rheumatoid arthritis.
“The citrulline antibody appears early in the course of rheumatoid arthritis and is present in the blood of most patients with the disease. When the citrulline antibody is detected in a patient's blood, there is a 90-95% likelihood that the patient has rheumatoid arthritis. The test for the citrulline antibody is therefore useful in the diagnosis of patients with unexplained joint inflammation, especially when the traditional blood test for rheumatoid factor is negative. The citrulline antibody also has prognostic (predictive) value since it is associated with a greater tendency toward more destructive forms of rheumatoid arthritis.”
2. The meaning of the anti-CCP test, from the website of the American College of Rheumatology: “Several observations have indicated that anti-CCP positive early RA patients may develop a more erosive disease than those without anti-CCP (6). Other investigators have confirmed this, and suggested the superiority of anti-CCP over RF [Rheumatoid Factor] in predicting an erosive disease course. The use of anti-CCP results in the decision whether a patient should be treated aggressively at an early stage or not is an important area for research.”
1. What is cyclic citrulline peptide (antibody)y, anti-CCP, quoted from MedicineNet.com: “Citrulline antibody: An antibody … directed against a circular peptide … containing an unusual ("non-standard") amino acid called citrulline that is not normally present in peptides or proteins. … The citrulline antibody provides the basis for a test of importance in rheumatoid arthritis.
“The citrulline antibody appears early in the course of rheumatoid arthritis and is present in the blood of most patients with the disease. When the citrulline antibody is detected in a patient's blood, there is a 90-95% likelihood that the patient has rheumatoid arthritis. The test for the citrulline antibody is therefore useful in the diagnosis of patients with unexplained joint inflammation, especially when the traditional blood test for rheumatoid factor is negative. The citrulline antibody also has prognostic (predictive) value since it is associated with a greater tendency toward more destructive forms of rheumatoid arthritis.”
2. The meaning of the anti-CCP test, from the website of the American College of Rheumatology: “Several observations have indicated that anti-CCP positive early RA patients may develop a more erosive disease than those without anti-CCP (6). Other investigators have confirmed this, and suggested the superiority of anti-CCP over RF [Rheumatoid Factor] in predicting an erosive disease course. The use of anti-CCP results in the decision whether a patient should be treated aggressively at an early stage or not is an important area for research.”